Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience-Reference-Cited by-同舟云学术

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience

Published:2022-12-01 Issue:4 Volume:39 Page:254-261
ISSN:1300-7777
Container-title:Turkish Journal of Hematology
language:
Short-container-title:Tjh

Author:

Özbalak Murat,Mastanzade Metban,Özden Özlük Dilek,Tiryaki Tarık Onur,Erdem Simge,Özbalak Ezgi Pınar,Elverdi Tuğrul,Yönal Hindilerden İpek,Altay Ali Yılmaz,Yeğen Gülçin,Eşkazan Ahmet Emre,Ar Muhlis Cem,Yenerel Mustafa Nuri,Soysal Teoman,Nalçacı Meliha,Ferhanoğlu Burhan,Kalayoğlu Beşışık Sevgi

Publisher

Galenos Yayinevi

Subject

Hematology

Reference30 articles.

1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

2. 2. US Food and Drug Administration. Biosimilars. Available at https://www.fda.gov/drugs/therapeutic-biologics-applications-bla/biosimilars.

3. 3. Muller R, Renner C, Gabay C, Cassata G, Lohri A, Hasler P. The advent of biosimilars: challenges and risks. Swiss Med Wkly 2014;144:w13980.

4. Comparison of the efficacy and safety of Rituximab (Mabthera) and its biosimilar (Reditux) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: a retrospective analysis;Roy;Indian J Med Paediatr Oncol,2013

5. R-CHOP chemotherapy with a rituximab biosimilar (Redditux®) for patients with de novo diffuse large B-cell lymphoma: first preliminary results of a real-life single-center experience from turkey;Özbalak;İstanbul Kanuni Sultan Süleyman Tıp Dergisi,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP;Annals of Hematology;2024-06-20